Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00516659 · ClinicalTrials.gov registry record · Phase 2
ETEC Logistics Trial (TREK)
A Phase 2 study of Diarrhea, sponsored by Intercell USA.
- Completed
- Registry status
- Phase 2
- Development phase
- 201
- Enrollment target
- 19
- Study locations
NCT00516659: Completed Phase 2 study of Diarrhea, sponsored by Intercell USA.
NCT00516659 is a Phase 2 study of Diarrhea that has completed, run by Intercell USA. The registered enrollment target is 201 participants, above the 149-participant average among 24 other Diarrhea trials with a reported enrollment target (35% higher). The trial reports 19 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00516659, a Phase 2 study of Diarrhea, has completed, sponsored by Intercell USA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 201 participants
- Enrollment target
- 19
- Study locations
Study Summary
This is a multicenter, double-blind, randomized, placebo-controlled field trial to evaluate the epidemiology of natural infection with ETEC occurring after transcutaneous immunization in a field setting.
Conditions Studied
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Heat-Labile Enterotoxin of Escherichia coli (LT)
Study Locations (19)
Texas
- Radiant Research - Dallas
- Breco Research - Houston
- Center for Infectious Diseases, The University of Texas Health Science Center at Houston - Houston
- Radiant Research - San Antonio
California
- West Coast Clinical Trials - Long Beach
Illinois
- Radiant Research - Chicago
Maryland
- Johns Hopkins University, Bloomberg School of Public Health - Baltimore
Minnesota
- Twin Cities Clinical Research - Minneapolis
New Jersey
- Advanced Biomedical Research - Hackensack
New York
- Asthma Allergy & Associates - Ithica
Ohio
- Radiant Research - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
What the finished NCT00516659 record still lists
NCT00516659 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, above the 149-participant average among 24 other Diarrhea trials with a reported enrollment target (35% higher).
The record links to 1 condition, with Diarrhea appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00516659 lists 19 locations in 16 states (Texas, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT00516659 about?
NCT00516659 is a clinical study titled "ETEC Logistics Trial (TREK)". This is a multicenter, double-blind, randomized, placebo-controlled field trial to evaluate the epidemiology of natural infection with ETEC occurring after transcutaneous immunization in a field setting.
What is the current status of trial NCT00516659?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 201 participants. The study started on 2006-05. Estimated completion is 2007-12.
What conditions does trial NCT00516659 study?
This clinical trial studies the following conditions: Diarrhea.
What interventions are being tested in trial NCT00516659?
The interventions under investigation include: Placebo (BIOLOGICAL), Heat-Labile Enterotoxin of Escherichia coli (LT) (BIOLOGICAL).
Who is sponsoring clinical trial NCT00516659?
This trial is sponsored by Intercell USA, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00516659 being conducted?
This trial has 19 study locations across California, Illinois, Maryland, Minnesota, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diarrhea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00516659's enrollment target sits among peer trials
201 7th of 24 higher than 18 of 24 other Diarrhea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diarrhea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fecal Microbiota Transplantation for IBS
RECRUITING · Phase 2
-
MTT for Children With ASD Who Have Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
COMPLETED · Phase 2
-
A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
COMPLETED · Phase 2
-
Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia